Zacks Investment Research upgraded shares of Medical Properties Trust (NYSE:MPW) from a sell rating to a hold rating in a research report released on Wednesday.
According to Zacks, “Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. “
A number of other equities analysts also recently weighed in on MPW. Stifel Nicolaus set a $14.00 target price on shares of Medical Properties Trust and gave the stock a hold rating in a report on Thursday, November 1st. Mitsubishi UFJ Financial Group boosted their target price on shares of Medical Properties Trust to $15.00 and gave the stock a neutral rating in a report on Friday, November 2nd. Jefferies Financial Group downgraded shares of Medical Properties Trust from a buy rating to a hold rating and set a $15.00 target price on the stock. in a report on Tuesday, July 17th. Finally, JMP Securities set a $16.00 target price on shares of Medical Properties Trust and gave the stock a buy rating in a report on Monday, October 1st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Medical Properties Trust currently has a consensus rating of Hold and an average price target of $14.19.
Shares of NYSE MPW traded up $0.13 during midday trading on Wednesday, reaching $16.72. The company’s stock had a trading volume of 3,628,080 shares, compared to its average volume of 2,947,199. The company has a quick ratio of 2.19, a current ratio of 4.92 and a debt-to-equity ratio of 0.90. Medical Properties Trust has a fifty-two week low of $11.82 and a fifty-two week high of $16.85. The company has a market capitalization of $6.11 billion, a PE ratio of 12.39, a price-to-earnings-growth ratio of 3.55 and a beta of 0.47.
Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.34 by $0.01. The business had revenue of $197.00 million for the quarter, compared to the consensus estimate of $192.64 million. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.33 earnings per share. As a group, sell-side analysts expect that Medical Properties Trust will post 1.37 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, October 11th. Investors of record on Thursday, September 13th were issued a dividend of $0.25 per share. The ex-dividend date was Wednesday, September 12th. This represents a $1.00 dividend on an annualized basis and a yield of 5.98%. Medical Properties Trust’s payout ratio is 74.07%.
In other Medical Properties Trust news, VP James Kevin Hanna sold 15,000 shares of Medical Properties Trust stock in a transaction on Friday, August 17th. The shares were sold at an average price of $14.84, for a total transaction of $222,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Emmett E. Mclean sold 100,000 shares of Medical Properties Trust stock in a transaction on Wednesday, August 22nd. The stock was sold at an average price of $14.93, for a total transaction of $1,493,000.00. Following the transaction, the insider now directly owns 963,965 shares of the company’s stock, valued at $14,391,997.45. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 127,400 shares of company stock valued at $1,890,812. Company insiders own 0.83% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board bought a new position in Medical Properties Trust during the third quarter worth $1,391,000. FMR LLC boosted its position in Medical Properties Trust by 96.7% during the third quarter. FMR LLC now owns 3,876,161 shares of the real estate investment trust’s stock worth $57,793,000 after purchasing an additional 1,905,961 shares during the period. Blue Sky Asset Management LLC bought a new position in Medical Properties Trust during the third quarter worth $1,091,000. American International Group Inc. boosted its position in Medical Properties Trust by 1.0% during the third quarter. American International Group Inc. now owns 741,645 shares of the real estate investment trust’s stock worth $11,058,000 after purchasing an additional 7,598 shares during the period. Finally, BlackRock Inc. boosted its position in Medical Properties Trust by 2.1% during the third quarter. BlackRock Inc. now owns 41,840,443 shares of the real estate investment trust’s stock worth $623,840,000 after purchasing an additional 846,940 shares during the period. 77.17% of the stock is owned by hedge funds and other institutional investors.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
See Also: Dividend Aristocrat Index
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.